Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine disease-free survival, overall survival, time to
progression, regimen-related toxicity and/or treatment-related mortality in patients with
hematologic malignancies treated with non-myeloablative chemotherapy followed by allogeneic
stem cell transplant.